GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

GlaxoSmithKline Pharmaceuticals

25/04/2024 14:18

By Blake Brittain
       April 25 (Reuters) - GlaxoSmithKline  GLAX.NS  sued
Pfizer  PFE.N  and BioNTech  22UAy.DE  in Delaware federal court
on Thursday, accusing them of infringing GSK patents related to
messenger RNA (mRNA) technology in the companies' blockbuster
COVID-19 vaccines.
    GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty
vaccines violate the company's patent rights in mRNA-vaccine
innovations developed "more than a decade before" the outbreak
of the COVID-19 pandemic.

 (Reporting by Blake Brittain)
 ((blake.brittain@thomsonreuters.com))